BLFS — BioLife Solutions Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for BioLife Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.4	69.9	62.7	51.7	105
Net Total Accounts Receivable
Net Total Receivables	8.01	23.2	33.9	18.7	9.17
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	115	126	138	121	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.5	46.6	48.3	40.3	22.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	235	554	450	413	399
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.6	42.7	44.6	42.2	32.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	29.6	76.2	86	75.1	50.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	205	478	364	338	349
Total Liabilities & Shareholders' Equity	235	554	450	413	399
Total Common Shares Outstanding
Total Preferred Shares Outstanding